Your browser doesn't support javascript.
loading
Recurrent FOXK1::GRHL and GPS2::GRHL fusions in trichogerminoma.
Kervarrec, Thibault; Pissaloux, Daniel; Poilane, Jeremie; Tirode, Franck; Tallet, Anne; Collin, Christine; Tallegas, Matthias; Berthon, Patricia; Gaboriaud, Pauline; Sohier, Pierre; Calonje, Eduardo; Luzar, Bostjan; Goto, Keisuke; Cokelaere, Kristof; Lamant, Laurence; Balme, Brigitte; Wild, Richard; Neuville, Agnes; Deschamps, Lydia; Auberger, Elisabeth; Paumier, Veronique; Bonte, Helene; Moulonguet, Isabelle; Plantier, Françoise; Cales, Valérie; Pinsolle, Vincent; Roblet, Denis; Dupuy, Frantz; Dallot, Alexiane; Seris, Alice; Jouary, Thomas; Houben, Roland; Schrama, David; Hesbacher, Sonja; Macagno, Nicolas; Battistella, Maxime; Cribier, Bernard; Vergier, Beatrice; de la Fouchardière, Arnaud; Jullie, Marie-Laure.
Afiliación
  • Kervarrec T; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Pissaloux D; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France.
  • Poilane J; CARADERM Network, Pau, France.
  • Tirode F; Department of Biopathology, Center Léon Bérard, Lyon, France.
  • Tallet A; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Collin C; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Tallegas M; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Berthon P; Department of Pathology, Centre Hospitalier Universitaire de Angers, Angers, France.
  • Gaboriaud P; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Sohier P; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Calonje E; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Luzar B; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Goto K; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Cokelaere K; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France.
  • Lamant L; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France.
  • Balme B; CARADERM Network, Pau, France.
  • Wild R; Faculté de Médecine Paris Centre Santé, University of Paris, Paris, France.
  • Neuville A; Department of Pathology, Hôpital Cochin, AP-HP Centre-Université de Paris, Paris, France.
  • Deschamps L; Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, UK.
  • Auberger E; Institute of Pathology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia.
  • Paumier V; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
  • Bonte H; Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.
  • Moulonguet I; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
  • Plantier F; Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.
  • Cales V; Department of Pathology, Jan Yperman Hospital, Ieper, Belgium.
  • Pinsolle V; CARADERM Network, Pau, France.
  • Roblet D; Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France.
  • Dupuy F; CARADERM Network, Pau, France.
  • Dallot A; Department of Pathology, Centre Hospitalier Universitaire de Lyon, Lyon, France.
  • Seris A; Cabinet de Pathologie Wild, Mulhouse, France.
  • Jouary T; Contades Office of Pathological Anatomy and Cytology, Strasbourg, France.
  • Houben R; CARADERM Network, Pau, France.
  • Schrama D; Department of Pathology, APHP Bichat Hospital, Paris, France.
  • Hesbacher S; Service d'Anatomie et Cytologie Pathologiques, Hopital Simone Veil, Eaubonne, France.
  • Macagno N; ATALANTE Pathologie, Rennes, France.
  • Battistella M; Centre Médical de Pathologie, Compiegne, France.
  • Cribier B; Cabinet Mathurin Moreau, Paris, France.
  • Vergier B; Department of Pathology, Hôpital Cochin, AP-HP Centre-Université de Paris, Paris, France.
  • de la Fouchardière A; Cabinet Mathurin Moreau, Paris, France.
  • Jullie ML; Department of Pathology, Centre Hospitalier de Pau, Pau, France.
J Pathol ; 257(1): 96-108, 2022 05.
Article en En | MEDLINE | ID: mdl-35049062
ABSTRACT
We report 21 cases of trichogerminoma harbouring previously undescribed FOXK1GRHL1/2 or GPS2GRHL1/2/3 in-frame fusion transcripts. Microscopic examination of a preliminary set of five cases revealed well-delimitated tumours located in the dermis with frequent extension to the subcutaneous tissue. Tumours presented a massive and nodular architecture and consisted of a proliferation of basaloid cells. A biphasic pattern sometime resulting in tumour cell nests ('cell balls') was present. Immunohistochemistry demonstrated the expression of cytokeratins (CKs) 15, 17, and PHLDA1. In addition, numerous CK20-positive Merkel cells were detected. RNA sequencing (RNA-seq) revealed a FOXK1GRHL1 chimeric transcript in three cases and a FOXK1GRHL2 fusion in two cases. In a second series for validation (n = 88), FOXK1GRHL1/2 fusion transcripts were detected by RT-qPCR or FISH in an additional 12 trichogerminomas and not in any other follicular tumour entities or basal cell carcinoma cases (n = 66). Additional RNA-seq analysis in trichogerminoma cases without detected FOXK1GRHL1/2 rearrangements revealed GPS2GRHL1 fusion transcripts in two cases, GPS2GRHL2 in one case, and GPS2GRHL3 fusion transcript in one case. Therefore, our study strongly suggests that GRHL1/2/3 gene rearrangements might represent the oncogenic driver in trichogerminoma, a subset of follicular tumours characterized by immature features and numerous Merkel cells. © 2022 The Pathological Society of Great Britain and Ireland.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Pathol Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Pathol Año: 2022 Tipo del documento: Article País de afiliación: Francia